Summary: OVERPRICED
Score: 4/20
MOS: -300%
Share Price: $75
Sticker Price: $18
Is Moderna a good buy?
Here is a perfect example of a speculative stock.
Moderna is currently working on a vaccine for COVID-19. They received funding from the United States “Operation Warp Speed program” for a potential solution. Stocks have soared nearly 300% this year based on hopes they will develop a successful vaccine.
See that word “HOPE”?
When it comes to investing, we don’t use the word HOPE. Hope is based on emotions and we don’t rely on emotions. We rely on LOGIC.
Let’s break this down…
The problem with Moderna, it’s not the only company working on a vaccine. Some of the other large companies include Inovio (INO), Sanofi (SNY), and Johnson & Johnson (JNJ).
One may think they should invest in all four stocks with the hopes that one of these will indeed invent the vaccine.
What if some small private pharma company invents the vaccine? Then nobody wins!
Overall, investing in Moderna is gambling. We don’t gamble. We buy businesses with great financials (Tykr SCORE) and a large sticker price to share price difference (Tykr MOS).
—
The Summary, Score, and MOS of this stock may have changed since the posting of this review. Please login to Tykr to see up-to-date information.